Vascular endothelial growth factor increases pulmonary vascular permeability in cystic fibrosis patients undergoing lung transplantation☆☆☆
Author(s) -
Katharina Krenn,
Walter Klepetko,
Shahrokh Taghavi,
Patrick Paulus,
Seyedhossein Aharinejad
Publication year - 2007
Publication title -
european journal of cardio-thoracic surgery
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.303
H-Index - 133
eISSN - 1873-734X
pISSN - 1010-7940
DOI - 10.1016/j.ejcts.2007.04.006
Subject(s) - vascular endothelial growth factor , lung transplantation , lung , transplantation , cd31 , medicine , vascular permeability , angiogenesis , pathology , hypoxia inducible factors , hypoxia (environmental) , biology , chemistry , vegf receptors , biochemistry , gene , organic chemistry , oxygen
Vascular endothelial growth factor (VEGF) is the prime regulator of angiogenesis and vascular permeability and its serum levels increase in cystic fibrosis (CF). The mechanisms of VEGF overproduction and its impact on CF lung pathology and pulmonary vascular permeability during lung transplantation are not fully understood.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom